ABSTRACT Ferula ferulaeoides (Steud.) Korov. (FFK) is an ethnomedicine for the treatment of gastrointestinal diseases. However, the lack of systematic quality control standards has hindered its market and clinical application. The purpose of this study is to carry out pharmacognostic identification and quality evaluation of FFK and to speed up the establishment of its quality control standards. The methods include organoleptic evaluation, microscopic observation, proximate analyses, chemical qualitative analysis, thin-layer chromatography (TLC) fingerprinting, and high-performance liquid chromatography (HPLC). The results showed that the leaves of FFK are light green, and the root is fusiform and thick. The resin is milky white in the fresh state and becomes a yellowish-brown irregular mass after air drying. Under the microscope, the secondary structure of the root was developed, and the resin ducts were mainly distributed in the cortex. The powder contained vessels, oil cells, fibers, starch granules, parenchyma cells, resin ducts, and stone cells, while the resin powder only contained resin mass. The contents of ash, water, extract, and heavy metals in FFK all met the general standards of similar medicinal materials in the Chinese Pharmacopoeia (ChP). Chemical qualitative analysis showed that FFK contained terpenoids, flavonoids, coumarins, and volatile oils. The TLC fingerprint of FFK was established. The results of HPLC showed that the content of ferulic acid in FFK was 0.5518 mg·g -1. This study preliminarily established the pharmacognosy identification standard of FFK and, combined with the quality evaluation of FFK, could lay a foundation for the comprehensive development and utilization of FFK.